GPC2 MAY BE AN IMMUNOTHERAPEUTIC TARGET IN HIGH-RISK NEUROBLASTOMA
AMER ASSOC CANCER RESEARCH
September 22, 2017
We’re excited to announce that effective September 2020, the CBTTC (cbttc.org) will be renamed as the Children’s Brain Tumor Network and this website URL will redirect to cbtn.org. This page will remain active but you will be redirected to new site content